CAG repeat length in the androgen receptor gene is related to age at diagnosis of prostate cancer and response to endocrine therapy, but not to prostate cancer risk

por Bratt, O, Borg, Å, Kristoffersson, U, Lundgren, R, Zhang, Q-X, Olsson, H
Publicado 1999

Open-label, clinical phase I studies of tasquinimod in patients with castration-resistant prostate cancer

por Bratt, O, Häggman, M, Ahlgren, G, Nordle, Ö, Björk, A, Damber, J-E
Publicado 2009

The Cambridge Prognostic Groups for improved prediction of disease mortality at diagnosis in primary non-metastatic prostate cancer: a validation study

por Gnanapragasam, V. J., Bratt, O., Muir, K., Lee, L. S., Huang, H. H., Stattin, P., Lophatananon, A.
Publicado 2018

Single institution followed by national implementation of systematic surgical quality control and feedback for radical prostatectomy: a 20-year journey

por Stranne, J., Axen, E., Franck-Lissbrant, I., Fransson, P., Frånlund, M., Hugosson, J., Khatami, A., Koss-Modig, K., Lodding, P., Nyberg, M., Stattin, P., Bratt, O.
Publicado 2019